GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Anavex Life Sciences AVXL · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.22

+6.09%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Anavex Life Sciences

From its filings with the US Securities and Exchange Commission

SEC filings

Anavex Life Sciences is based in New York, New York. Its shares trade on Nasdaq under the ticker AVXL. The SEC classifies its business as biological products, (no diagnostic substances). In the fiscal year to 30 September 2025, it reported a net loss of $46.4m. At that date it held total assets of $103.8m and shareholders' equity of $94.9m.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
13 Apr 2006
Employees
34
Website
anavex.com ↗
Head office
630 5TH AVENUE, NEW YORK, NY, 10111
Classification
Biological Products, (No Diagnostic Substances)
Filer status
Large accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Ms. Jiong MaIndependent Chairman of the Board$243,200
  • Dr. Christopher MisslingPresident, Chief Executive Officer, Secretary, Director, since 2013$2.8m
  • Ms. Sandra BoenischPrincipal Financial Officer, Treasurer$402,227
  • Dr. Peter DonhauserIndependent Director$227,200
  • Mr. Athanasios SkarpelosIndependent Director$227,200
  • Dr. Steffen ThomasIndependent Director$227,200
  • Dr. Claus van Der VeldenIndependent Director$243,200

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
51
Environment
48
Social
55
Governance
52
Women in the workforce
55%
Carbon reduction policy
No
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Anavex Life Sciences Corp possesses several strengths that contribute to its success:

Weaknesses

  • Anavex Life Sciences Corp should address the following weaknesses to mitigate potential risks:

Opportunities

  • Several opportunities can be explored by Anavex Life Sciences Corp to drive future growth:

Threats

  • Anavex Life Sciences Corp should be prepared for these potential threats that could impact its business:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.